Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Clinical trial NCT02187003 · COMPLETED
Trial details
- NCT number
- NCT02187003
- Sponsor
- Biossil Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-17
- Primary completion
- 2019-05-03
- Enrollment
- 345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.